Skip to content
AnalystLens

IQVIA Holdings 8-K Report, Financial Results (May 5, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed May 5, 2026
Period End
May 5, 2026
Security
IQV
In the record · 2016–202610-K1110-Q338-K130

IQV filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Dec ’16Dec ’16
  2. Leadership change8-K · Feb ’19Feb ’19
  3. Material agreement8-K · Mar ’21Mar ’21
  4. Material agreement8-K · Jun ’25Jun ’25

01—Abstract

Summary

Summary of the 8-K filed May 5, 2026. Cited figures are marked; the original filing is the authoritative source.

IQVIA Holdings Inc. (NYSE: IQV) furnished its press release reporting first-quarter 2026 results for the quarter ended March 31, 2026, under Item 2.02 of Form 8-K.

Revenue was $4,151 milliona, up 8.4% on a reported basis and 6.0% at constant currency. GAAP net income attributable to IQVIA was $274 million, or $1.61 per diluted share, and Adjusted EBITDA was $932 million, up 5.5% year-over-year. Adjusted diluted EPS was $2.90, up 7.4%.

Commercial Solutions revenue grew 11.6% on a reported basis to $1,754 millionb, while R&D Solutions revenue rose 6.2% to $2,397 million. The company now reports two segments, Commercial Solutions and Research & Development Solutions, following a reorganization effective January 1, 2026. R&DS contracted backlog stood at $34.2 billion at quarter-end, with net new bookings of $2.5 billion and a book-to-bill ratio of 1.04x for the quarter.

The company expects approximately $8.9 billionc of backlog to convert to revenue in the next twelve months. Operating cash flow was $618 million and free cash flow was $491 million, up 15% year-over-year. IQVIA repurchased $552 million of common stock in the quarter and had $1,217 million of authorization remaining.

Net debt was $13,886 milliond, and the Net Leverage Ratio was 3.62x trailing twelve-month Adjusted EBITDA. For full-year 2026, IQVIA reaffirmed revenue guidance of $17,150 million to $17,350 million and Adjusted EBITDA guidance of $3,975 million to $4,025 million, and raised Adjusted Diluted EPS guidance to $12.65 to $12.95. Revenue guidance assumes about 150 basis points of acquisition contribution and an approximately 100 basis point foreign exchange tailwind.

02—Key points

Key Highlights

  1. Revenue of $4,151 million, up 8.4% reported and 6.0% at constant currency year-over-year.
  2. Adjusted Diluted EPS of $2.90 (up 7.4%) versus GAAP Diluted EPS of $1.61; Adjusted EBITDA of $932 million, up 5.5%.
  3. Commercial Solutions revenue rose 11.6% reported to $1,754 million; R&D Solutions revenue rose 6.2% reported to $2,397 million.
  4. R&DS contracted backlog of $34.2 billion, with $2.5 billion of net new bookings and a 1.04x quarterly book-to-bill ratio.
  5. Free cash flow of $491 million, up 15% year-over-year, equal to 100% of Adjusted Net Income.
  6. Repurchased $552 million of common stock; $1,217 million of authorization remained at March 31, 2026.
  7. Net Leverage Ratio of 3.62x; full-year 2026 Adjusted Diluted EPS guidance raised to $12.65 to $12.95, while revenue and Adjusted EBITDA guidance were reaffirmed.

03—Questions

Frequently Asked Questions

  1. Did IQVIA change its full-year 2026 guidance?

    Yes, in part. IQVIA reaffirmed full-year 2026 revenue guidance of $17,150 million to $17,350 million and Adjusted EBITDA guidance of $3,975 million to $4,025 million. It raised Adjusted Diluted EPS guidance to $12.65 to $12.95.

  2. How did the two segments perform in the first quarter?

    Commercial Solutions revenue was $1,754 million, up 11.6% reported and 8.5% at constant currency. R&D Solutions revenue was $2,397 million, up 6.2% reported and 4.2% at constant currency; excluding reimbursed expenses, R&DS revenue grew 6.6% reported.

  3. How strong is the R&DS backlog and bookings position?

    R&DS contracted backlog was $34.2 billion at March 31, 2026. The company expects approximately $8.9 billion of this to convert to revenue in the next twelve months. First-quarter net new bookings were $2.5 billion, with a book-to-bill ratio of 1.04x and a trailing-twelve-month book-to-bill ratio of 1.11x.

  4. What is IQVIA's balance sheet and leverage position?

    At March 31, 2026, cash and cash equivalents were $1,947 million and debt was $15,833 million, for net debt of $13,886 million. The Net Leverage Ratio was 3.62x trailing twelve-month Adjusted EBITDA, and the Gross Leverage Ratio was 4.13x.

  5. Is the GAAP-to-non-GAAP difference significant?

    Yes. GAAP diluted EPS was $1.61 compared with Adjusted Diluted EPS of $2.90. The reconciliation adds back purchase accounting amortization of $137 million, stock-based compensation of $65 million, and restructuring and related expenses of $53 million, among other items.

04—Continue

← View all 8-K filings